Tremendous strides have been made in the treatment of various oncological diseases such
that patients are surviving longer and are having better quality of life. However, the success …

Cardiotoxic effects of chemotherapy and targeted drugs are ubiquitous and challenging in
the field of oncology therapeutics. The broad spectrum of toxicities ranging from ischemic …

Although outcomes in cancer patients have dramatically improved with the development of
novel cancer chemotherapies and combination treatment, these developments are …

Cardiotoxicity is a common complication of many anti-cancer agents and it remains a major
limitation, strongly impacting the quality of life and the overall survival, regardless of the …

Cardiovascular toxicity is a potential short-or long-term complication of anticancer therapy.
Exposure to chemotherapy medications, primarily the anthracycline class, can lead to …

Chemotherapy and targeted therapies have significantly improved the prognosis of
oncology patients. However, these antineoplastic treatments may also induce adverse …

As medicine advances to employ sophisticated anticancer agents to treat a vast array of
oncological conditions, it is worth considering side effects associated with several …

In recent years, the development of more effective drugs has provided a better prognosis
and an increase in life expectancy for patients at all-stages of cancer. On the other hand, the …

The cardiotoxicity of anticancer agents can lead to significant complications that can affect
patients being treated for various malignancies. The severity of such toxicity depends on …

Drug-induced cardiotoxicity is emerging as an important issue among cancer survivors. For
several decades, this topic was almost exclusively associated with anthracyclines, for which …